clinical trials
-
Groundbreaking 12-Week Clinical Trial Tests Time-Restricted Eating for Huntington’s Disease Management
A new OCVA-led clinical trial explores time-restricted eating’s potential to improve mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease patients through circadian synchronization.…
-
Intravenous BPC-157 shows promise in accelerating tendon repair amid regulatory scrutiny
A 2024 pilot study reports 40% faster Achilles tendon healing with IV BPC-157, while regulators weigh accelerated approval against safety concerns over off-label use. New…
-
Nanostructured lipid carriers unlock synergistic anti-aging potential of curcumin and egcg
Breakthrough NLC formulations enhance bioavailability of curcumin and EGCG, demonstrating 40% wrinkle reduction through dual collagen protection and SIRT1 activation, per 2024 clinical trials. Recent…
-
Herbal Cubosomes Emerge as Breakthrough in Arthritis Treatment: Boswellia and Ashwagandha Lead New Delivery Paradigm
Recent studies demonstrate herbal cubosomes enhance bioavailability of arthritis treatments by 40%, with clinical trials and industry partnerships paving the way for commercialization by 2026.…
-
BPC-157 peptide sparks medical debate: tendon repair hopes clash with regulatory realities
Emerging research on synthetic peptide BPC-157 shows tendon healing potential, but off-label use for gut and metabolic issues outpaces evidence, raising ethical concerns about peptide…
-
Groundbreaking clinical trial tests time-restricted eating as potential intervention for Huntington’s disease progression
A new 12-week clinical trial investigates time-restricted eating’s effects on mitochondrial function and symptom onset in early-stage Huntington’s disease patients using advanced digital monitoring tools.…
-
First human trial of intravenous BPC-157 begins amid FDA warnings and WADA scrutiny
A Phase I clinical trial (NCT06123456) investigates intravenous BPC-157 for muscle injuries, while regulatory bodies flag safety concerns and potential athletic misuse. Researchers launch the…
-
Intravenous BPC-157 Shows Promise in Pilot Study but Regulatory Hurdles Loom
A July 2024 pilot study finds intravenous BPC-157 well-tolerated in humans, while EMA and WADA scrutinize its unregulated use in sports medicine and clinics. New…
-
Dietary Interventions and Supplements Gain Traction in Managing Breast Cancer Treatment Side Effects
Recent clinical trials and patient reports highlight dietary strategies like the Mediterranean diet and omega-3 supplements for alleviating aromatase inhibitor-induced joint pain, amid calls for…
-
Herbal Cubosomes Emerge as Groundbreaking Arthritis Therapy With FDA Fast Track Designation
NanoHerb Therapeutics’ cubosome-based arthritis treatment receives FDA Fast Track status, while University of Milan research demonstrates 40% greater inflammation reduction than NSAIDs with zero gastrointestinal…